About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Diabetes Clinical Trials in Michigan | 20 Studies

Clinical Trials DiabetesMichigan

Diabetes Clinical Trials in Michigan

Find 20 clinical trials for diabetes near Michigan. Connect with research centers in your area.

All Diabetes trials nationwide All trials in Michigan

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1-20 of 20 trials

CompletedStudy of a High-Dose Aflibercept in Participants With Diabetic Eye DiseaseThe primary objective of the study is to determine if treatment with high-dose aflibercept (HD) at intervals of 12 or 16 weeks provides non-inferior best corrected visual acuity…NCT04429503·Phoenix, Arizona and 137 others

Diabetes Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingEfficacy of the Omnipod® 6 System Compared With the Omnipod® 5 SystemThis multi-center, randomized, cross-over trial will evaluate the efficacy of the Omnipod 6 System compared with the Omnipod 5 System in individuals with type 1 or type 2 diabetes…NCT07579702·Los Angeles, California and 10 others

CompletedRenal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007)The purpose of this study is to assess the safety, efficacy, and durability of up to two Renal Autologous Cell Therapy (REACT) / rilparencel injections delivered percutaneously…NCT05018416·Denver, Colorado and 4 others

RecruitingPhase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 DiabetesDiabetic ketoacidosis (DKA) is increasingly recognized in adults with "ketone-prone" type 2 diabetes.NCT07167693·Detroit, Michigan

CompletedA 2-Month Safety Follow-Up TrialThe main purpose of the trial is to evaluate pulmonary function in subjects who had completed any one of the 4 MKC parent trials (MKC-TI-009, MKC-TI-102, MKC-TI-103, or…NCT00741429·Birmingham, Alabama and 149 others

Active not recruitingEversense® Non-adjunctive Use Post Approval StudyThis is a non-blinded, prospective, multi-center, single arm longitudinal cohort study (patient serving as their own control), to evaluate the effectiveness of diabetes with the…NCT04836546·Los Angeles, California and 22 others

CompletedClinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes MellitusThis open-label, multicenter study is designed to investigate the clinical utility and safety of pramlintide treatment in subjects with type 1 and type 2 diabetes who are failing…NCT00108004·Anaheim, California and 47 others

CompletedPost Approval Study of the Eversense® Continuous Glucose MonitoringA Post Approval Study to Evaluate the Long-term Safety and Effectiveness of the Eversense® Continuous Glucose Monitoring (CGM) System over repeat insertion and removal cycles and…NCT03908125·Newport Beach, California and 16 others

SuspendedEvaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 DiabetesThe Revita® system is being investigated to assess the efficacy of DMR versus Sham on improvement in Glycemic, Hepatic and Cardiovascular endpoints for patients with Type 2…NCT04419779·Phoenix, Arizona and 57 others

TerminatedEvaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary DiseaseExamine the effects of TI in combination with an anti-diabetic regimen including inhaled insulin versus anti-diabetic treatment without inhaled insulin on lung function \&…NCT00642616·Mission Hills, California and 20 others

CompletedOmnipod® SmartAdjust 2.0 System Compared to the Omnipod® 5 System in Individuals With Type 1 or Type 2 DiabetesThe goal of this multi-center, randomized, cross-over study is to evaluate the safety and effectiveness of the Omnipod 5 SmartAdjust 2.0 System in individuals with type 1 or type…NCT06865989·Los Angeles, California and 10 others

CompletedEfficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 DiabetesThe purpose of this study is to evaluate the safety and effectiveness of alogliptin combined with metformin, once daily (QD) or twice daily (BID), in participants with Type 2…NCT01023581·Dothan, Alabama and 200 others

CompletedAn Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 DiabetesThis is an open label, observational study designed to collect data that characterize the use of SYMLIN following the introduction of the medication into the marketplace.NCT00229658·Birmingham, Alabama and 106 others

CompletedAfrezza® INHALE-1 Study in PediatricsINHALE-1 is a Phase 3, open-label, randomized clinical study evaluating the efficacy and safety of Afrezza in combination with a basal insulin (i.e., the Afrezza group) versus…NCT04974528·Los Angeles, California and 38 others

TerminatedEfficacy of Aliskiren in the Treatment of Diabetic Macular EdemaTo assess the efficacy of oral aliskiren as a therapy for diabetic macular edemaNCT00768040·Phoenix, Arizona and 11 others

CompletedDiabetes Telemedicine Consultation: A Systems Improvement InterventionThis study seeks to evaluate and document the processes of outreach consultation through joint-clinics via teleconferencing as an intervention for system improvement in care…NCT00119041·Ann Arbor, Michigan and 1 other

RecruitingSafety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With DiabetesA 13-week multi-center single-arm trial, preceded by a 2-week standard therapy phase, will be conducted to assess the safety of MODI, an insulin titration algorithm, in adults…NCT07599982·Baltimore, Maryland and 5 others

CompletedSafety of Inhaled Insulin With Type 1 and Type 2 DiabetesPulmonary Safety in Diabetics with T/INCT00308737·Phoenix, Arizona and 175 others

CompletedEvaluation of Corneal Confocal Microscopy for the Identification and Prediction of Neuropathy in Type 1 DiabetesThrough the multinational pooled dataset approach, this trial will aim to derive and validate specific in vivo Corneal Confocal Microscopy (CCM) parameter thresholds for the…NCT02423434·Ann Arbor, Michigan and 4 others

CompletedComparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin GlarginePrimary Objective: To demonstrate non-inferiority of SAR341402 versus NovoLog/NovoRapid in glycated hemoglobin A1c (HbA1c) change from baseline to Week 26 in participants with…NCT03211858·Little Rock, Arkansas and 81 others

Other Conditions in Michigan

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia